Navigator
The NICaS Hemodynamic NAVIGATOR™(US Patent) is a revolutionary tool that provides the physician with an easy way to navigate their patient’s hemodynamic condition.
Key Advantages
The NAVIGATOR™ enables the decision-maker (treating physician, NP) to manage each patient with the help of a personal and comprehensive hemodynamic profile (information otherwise only available in high-level hospital care).
By utilizing this information, healthcare providers can treat their patients better, also substantially reducing readmission rates, thus lowering the economic and clinical burden of heart failure (as well as other conditions) while treating the patient continuously via drug titration, optimizing their therapy.
Related Clinical Studies
Pharmacologic treatment of hypertension guided by non-invasive haemodynamics in primary care improves blood pressure control
Authors: D Romer, J Cleland, P Sobotka, R Matthews, R Kaiser, I Granov, J Froehlich, M Perez, F Colangelo, R Crossey, M Bottorff, C Hardtke,
Hypertensive vs. normotensive blood pressure response to advanced conduction disorders: comparison of baseline non-invasive haemodynamic evaluation
Authors: Katia Orvin, Shelly Vons, Alon Barsheshet, Ciel Zehavi, Gregory Golovchiner, Georgy Rusadze, Ori Rahat, Ran Kornowski, Tsahi T Lerman, Aharon Erez Conclusions: Haemodynamic presentations
Whole-Body Impedance Cardiography-Derived Haemodynamic Parameters Associated With Outcomes in Clinically Stable Heart Failure Patients With Reduced Ejection Fraction
Authors: Emelissa J Valcourt; Olivia Pieroni; Karen E Alvarez; Mohammad Zahurul Islam; Hilary Bews; Aleksander Dokollari; Anita Soni; Shelley Zieroth; Ashish H Shah Conclusions: Non-invasively obtained resting SI
Acute Hemodynamic Changes Induced by Cardiac Contractility Modulation Evaluated Using the NICaS® System: A Pilot Study
Authors: Andrea Madeo, Silvana De Bonis, Anna Lucia Cavaliere, Giovanni Bisignani Heart failure (HF) with reduced ejection fraction remains a significant global health challenge despite
Utility of NICaS Non-Invasive Hemodynamic Monitoring in Critically Ill Patients with COVID-19
Authors: Wisam Zabeeda, Jonah Benjamin Cohen, Anat Reiner Benaim, Shiri Zarour, Yael Lichter, Idit Matot, Or Goren Conclusion: Non-invasive hemodynamic monitoring via the NICaS device
The Impact of Positive Inotropic Therapy on Hemodynamics and Organ Function in Acute Heart Failure: A Differentiated View
Authors: Juan Cheko, Nikolaos Patsalis, Julian Kreutz, Dimitar Divchev, Georgios Chatzis, Bernhard Schieffer, Birgit Markus Conclusion: Patients with acute decompensated HF benefit from positive inotropic
Contact Us
